The result indicated that HTR1A was expressed at low levels in ovarian serous cystadenocarcinoma (OV) and glioblastoma multiforme (GBM) while being highly expressed in brain lower grade glioma (LGG) (Figure 3A). Here, HTR1A is linked to central nervous system cancer.